IRIDEX Overview
- Founded
-
1989
- Status
-
Public
- Employees
-
170
- Stock Symbol
-
IRIX
- Investments
-
3
- Share Price
-
$3.37
- (As of Friday Closing)
IRIDEX General Information
Description
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, service and support activities. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific Rim.
Contact Information
Website
www.iridex.com
Formerly Known As
IRIS Medical Instruments
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Primary Office
- 1212 Terra Bella Avenue
- Mountain View, CA 94043
- United States
+1 (650) 000-0000
IRIDEX Timeline
IRIDEX Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.37 | $3.41 | $2.45 - $9.46 | $54.2M | 15.9M | 36.4K | -$0.35 |
IRIDEX Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 52,341 | 74,264 | 27,451 | 21,324 |
| Revenue | 55,331 | 53,903 | 36,347 | 43,447 |
| EBITDA | (4,772) | (4,382) | (5,799) | (8,077) |
| Net Income | (5,606) | (5,225) | (6,329) | (8,813) |
| Total Assets | 48,024 | 48,687 | 27,969 | 34,813 |
| Total Debt | 2,417 | 2,656 | 4,188 | 3,209 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
IRIDEX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IRIDEX Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery
Other Devices and Supplies
Mountain View, CA
170
As of 2022
000.00
000000000 -
000.00
00000
t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
00000000000 0000000
Lake Forest, CA
000
As of 0000
00000000
000000
it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000 0000000
Kalamazoo, MI
00000
As of 0000
00000000
Add Comparison
IRIDEX Competitors (17)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Staar Surgical | Corporate Backed or Acquired | Lake Forest, CA | 000 | 00000000 | ||
| 0000000 | Formerly VC-backed | Kalamazoo, MI | 00000 | 00000000 | ||
| 0000 0000000 | Formerly PE-Backed | Clearwater, FL | 000 | 0000 | 00000000 | 0000 |
| 0000000 | Formerly VC-backed | San Clemente, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000 0000000 0000 | Corporation | Mawson Lakes, Australia | 000 | 000.00 | 000000000 | 000.00 |
IRIDEX Patents
IRIDEX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200206521-A1 | Electrical methods and devices for ophthalmic treatment | Pending | 27-Dec-2018 | 00000000000 | |
| US-20200069463-A1 | Methods and systems for large spot retinal laser treatment | Pending | 31-Aug-2018 | 000000000 | |
| EP-3843642-A1 | Methods and systems for large spot retinal laser treatment | Pending | 31-Aug-2018 | 000000000 | |
| US-11351059-B2 | Probes having fiber taper and fluid collection channel for ophthalmic laser treatment | Active | 17-Aug-2018 | 000000000 | |
| US-20200054488-A1 | Probes having fiber taper and fluid collection channel for ophthalmic laser treatment | Granted | 17-Aug-2018 | A61F9/00781 |
IRIDEX Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Fuad Ahmad | Interim Chief Financial Officer | ||
| Patrick Mercer | Chief Operating Officer, Operations | ||
| David Bruce | Chief Executive Officer & Board Member |
IRIDEX Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Beverly Huss | Self | Board Member | 000 0000 |
| David Bruce | Self | Chief Executive Officer & Board Member | 000 0000 |
| Kenneth Ludlum | IRIDEX | Board Member | 000 0000 |
| Maria Sainz | IRIDEX | Board Member | 000 0000 |
| Nandini Devi | IRIDEX | Board Member | 000 0000 |
IRIDEX Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
IRIDEX Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (00000 | 10-Mar-2021 | 000000000 | Buildings and Property | 00000 000 | |
| 000000 000000 | 10-Mar-2021 | 0000000000 | 00.000 | Diagnostic Equipment | 00000 000 |
| RetinaLabs (Ophthalmology Line) | 08-Apr-2010 | Merger/Acquisition | 00.00 | Other Commercial Products | 00000000 |